Menon M, et al.. A peripheral blood gene expression signature for subclinical acute rejection and associated long-term graft injury. Am J Transplant 2014; 14:220–232.
O’Connell PJ, et al.. Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: A multicentre, prospective study. Lancet 2016; 388:983–993.
Parikh CR, et al.. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011; 22:1748–1757.
Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: Pathogenesis, risk factors, and prevention. Biomed Res Int 2014; 2014:741018.
Michael A, et al.. Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media. Biomed Res Int 2014; 2014:249810.
McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51:1419–1428.
Haase M, et al.. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57:1752–1761.
Lahoti A, et al.. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 2010; 116:4063–4068.
Gaspari F, et al.. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: A pilot prospective case-control study. Nephron Clin Pract 2010; 115:c154–c160.
Cooper DS, et al.. Follow-up renal assessment of injury long-term after acute kidney injury (FRAIL-AKI). Clin J Am Soc Nephrol 2016; 11:21–29.
Alderson HV, et al.. The associations of blood kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin with progression from CKD to ESRD. Clin J Am Soc Nephrol 2016; 11:2141–2149.
Trevisani F, et al.. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. Br J Cancer 2016; 115:1343–1350.